Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

177Lu-DTPA-omburtamab

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Y-mAbs Therap

Drug class:

Ionizing radiation emitter, B7-H3 inhibitor

Related drugs:

‹

›